Targeting the glycan of receptor binding domain with jacalin as a novel approach to develop a treatment against COVID-19.

Rajendaran, Senthilnathan; Jothi, Arunchalam; Anbazhagan, Veerappan.

Afiliação

Rajendaran S; School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu 613 413, India.
Jothi A; School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu 613 413, India.
Anbazhagan V; School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu 613 413, India.

R Soc Open Sci ; 7(9): 200844, 2020 Sep.

Article em En | MEDLINE | ID: mdl-33047045